Alejandro Valcuende-Rosique

6PUBLICATIONS
4CO-AUTHORS
Sport and exercise nutritionNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Vision scienceBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
The CONUT Score Independently Predicts Mortality in Older Patients with Hip Fracture.

|Feb 26, 2026
Safety profile of tofersen in amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Francisco José Tarazona-Santabalbina, Angel Belenguer-Varea, Joaquin Borrás-Blasco

|Feb 20, 2026
Impact of immune-related toxicity on survival and treatment response in non-small cell lung cancer patients.

Alejandro Valcuende-Rosique, Corina Escoín-Pérez, Agustín Sánchez-Alcaraz

|Feb 16, 2026
Letter to the Editor Regarding 'National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort Study'.

Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo-Uixeda

|Oct 13, 2025
Letter to the editor on "Effectiveness, safety and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study".

Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo-Uixeda

|Aug 04, 2025
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).

Joaquin Borras-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo-Uixeda

Pageof 1

Frequent Collaborators

3 joint publications

Joaquin Borras-Blasco

3 joint publications

Silvia Cornejo-Uixeda

1 joint publications

Javier Valcuende-Rosique

1 joint publications

Francisco José Tarazona-Santabalbina